TrainPain
Neuroplasticity Training Technology
Company Overview
Snapshot
Founded in July 2017 by Elan Schneider and Laurence Nash, TrainPain operates with 1–10 employees. The company has raised $1M across one funding round from 3 investors. In September 2018, TrainPain secured seed funding from Merchavia Holdings and Israel Innovation Authority.
Business overview
TrainPain develops science-based digital products focused on improving mental and emotional well-being for individuals experiencing neuropathic and fibromyalgia pain. The company's core technology promotes brain health through neuroplasticity exercises, targeting sensory-perceptual processes to reduce pain-related hypersensitivity. TrainPain integrates wearable hardware with personalized sensory training games, available in virtual reality and smartphone formats, alongside a virtual pain coach. The platform serves patients in the Digital Healthcare and Digital Therapeutics sectors, operating across B2C, B2B, and B2B2C business models in global markets, including the United States.
Strategic signal
In December 2020, TrainPain reported successful trial results for its fibromyalgia treatment. This indicates potential clinical validation for its neuro-rehabilitation technology, suggesting a positive trajectory for its digital therapeutics platform in addressing chronic pain conditions.
Log in to access full profile ›Company Intelligence Q&A
- What is TrainPain's primary focus?
- TrainPain specializes in neuroplasticity training technology, developing digital products to enhance mental and emotional well-being for individuals with neuropathic and fibromyalgia pain.
- When was TrainPain founded and by whom?
- TrainPain was founded in July 2017 by Elan Schneider and Laurence Nash.
- What is the total capital raised by TrainPain?
- TrainPain has raised a total of $1M across one funding round.
- Which investors participated in TrainPain's seed round?
- In September 2018, TrainPain secured seed funding from Merchavia Holdings and Israel Innovation Authority.
- What was a key development for TrainPain in late 2020?
- In December 2020, TrainPain announced successful trial results for its fibromyalgia treatment, highlighting progress in its game-based neuro-rehabilitation approach.